this calculation more accurately reflects the significant reduction of nk activity that occurs in patients with localized and systemic disease on chemotherapy when compared to untreated patients with no current evidence of disease ( 10.3 % and 14.9 % versus 30.7 % , respectively ; p less than 0.001 ) .
C0442893
systemic disease
C0012634
disease